Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 168

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis

Open access
Ferreira, Giovanni E, McLachlan, Andrew J, Lin, Chung-Wei Christine, Zadro, Joshua R, Abdel-Shaheed, Christina, O’Keeffe, Mary, Maher, Chris G · 2021 · BMJ

Published version of a preprint

Abstract

Objective: To investigate the efficacy and safety of antidepressants for back and osteoarthritis pain compared with placebo. Design: Systematic review and meta-analysis. Data sources: Medline, Embase, Cochrane Central Register of Controlled Trials, CINAHL, International Pharmaceutical Abstracts, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform from inception to 15 November and updated on 12 May 2020. Eligibility criteria for study selection: Randomised controlled trials comparing the efficacy or safety, or both of any antidepressant drug with placebo (active or inert) in participants with low back or neck pain, sciatica, or hip or knee osteoarthritis. Data extraction and synthesis: Two independent reviewers extracted data. Pain and disability were primary outcomes. Pain and disability scores were converted to a scale of 0 (no pain or disability) to 100 (worst pain or disability). A random effects model was used to calculate weighted mean differences and 95% confidence intervals. Safety (any adverse event, serious adverse events, and proportion of participants who withdrew from trials owing to adverse events) was a secondary outcome. Risk of bias was assessed with the Cochrane Collaboration’s tool and certainty of evidence with the grading of recommendations assessment, development and evaluation (GRADE) framework. Results: 33 trials (5318 participants) were included. Moderate certainty evidence showed that serotonin-noradrenaline reuptake inhibitors (SNRIs) reduced back pain (mean difference −5.30, 95% confidence interval −7.31 to −3.30) at 3-13 weeks and low certainty evidence that SNRIs reduced osteoarthritis pain (−9.72, −12.75 to −6.69) at 3-13 weeks. Very low certainty evidence showed that SNRIs reduced sciatica at two weeks or less (−18.60, −31.87 to −5.33) but not at 3-13 weeks (−17.50, −42.90 to 7.89). Low to very low certainty evidence showed that tricyclic antidepressants (TCAs) did not reduce sciatica at two weeks or less (−7.55, −18.25 to 3.15) but did at 3-13 weeks (−15.95, −31.52 to −0.39) and 3-12 months (−27.0, −36.11 to −17.89). Moderate certainty evidence showed that SNRIs reduced disability from back pain at 3-13 weeks (−3.55, −5.22 to −1.88) and disability due to osteoarthritis at two weeks or less (−5.10, −7.31 to −2.89), with low certainty evidence at 3-13 weeks (−6.07, −8.13 to −4.02). TCAs and other antidepressants did not reduce pain or disability from back pain. Conclusion: Moderate certainty evidence shows that the effect of SNRIs on pain and disability scores is small and not clinically important for back pain, but a clinically important effect cannot be excluded for osteoarthritis. TCAs and SNRIs might be effective for sciatica, but the certainty of evidence ranged from low to very low. Systematic review registration: PROSPERO CRD42020158521.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.m4825

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 50

  1. 10.1016/S0140-6736(18)32279-7 · DOI · Paper page
  2. 10.1136/annrheumdis-2013-204763 · DOI · Paper page
  3. 10.1016/j.spinee.2011.03.017 · DOI · Paper page
  4. 10.1017/S0033291716002099 · DOI
  5. 10.1371/journal.pone.0231675 · doi:10.1371/journal.pone.0231675
  6. 10.1016/j.joca.2019.06.011 · DOI · Paper page
  7. 10.1002/art.41142 · DOI · Paper page
  8. 10.1136/bmj.e497 · DOI · Paper page
  9. 10.7326/M16-2458 · DOI · Paper page
  10. 10.3904/kjim.2018.460 · DOI
  11. 10.1016/j.jclinepi.2019.12.006 · DOI
  12. 10.1136/bmj.b2535 · DOI · Paper page
  13. 10.1136/bmj.d5928 · DOI · Paper page
  14. 10.1002/ejp.1505 · DOI
  15. 10.1016/j.jclinepi.2013.02.018 · DOI
  16. 10.1001/jamainternmed.2016.1251 · DOI · Paper page
  17. 10.1016/j.joca.2015.07.001 · DOI
  18. Bellamy, 1988, Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, 15, 1833
  19. 10.1097/ALN.0000000000000902 · DOI
  20. 10.1371/journal.pone.0195776 · DOI
  21. 10.1016/j.pain.2006.10.029 · DOI · Paper page
  22. 10.1016/j.jpain.2005.05.002 · DOI
  23. 10.1097/00007632-198307000-00012 · doi:10.1097/00007632-198307000-00012
  24. 10.1097/BRS.0000000000001707 · DOI
  25. 10.4088/PCC.14m01658 · DOI
  26. 10.1016/j.jpain.2010.03.002 · DOI · Paper page
  27. 10.1111/j.1468-1331.2009.02648.x · DOI · Paper page
  28. 10.1097/BRS.0b013e3181d3cef6 · DOI · Paper page
  29. 10.1176/appi.psy.41.6.490 · DOI
  30. 10.1097/00004714-199008000-00006 · doi:10.1097/00004714-199008000-00006
  31. Jenkins, 1976, Tofranil in the treatment of low back pain, J Int Med Res, 4, 28
  32. 10.2147/JPR.S164128 · DOI
  33. 10.1016/j.joca.2016.12.025 · DOI
  34. 10.1016/j.pain.2009.06.024 · DOI · Paper page
  35. 10.1111/j.1533-2500.2010.00401.x · DOI · Paper page
  36. 10.1185/03007995.2011.633502 · DOI
  37. Alcoff, 1982, Controlled trial of imipramine for chronic low back pain, J Fam Pract, 14, 841
  38. Hameroff, 1982, Doxepin effects on chronic pain, depression and plasma opioids, J Clin Psychiatry, 43, 22
  39. Pirbudak, 2003, Epidural steroid injection and amitriptyline in the management of acute low back pain originating from lumbar disc herniation, Joint Dis Rel Surg., 14, 89
  40. 10.1093/ageing/afs072 · DOI
  41. 10.1002/ejp.1206 · DOI
  42. 10.1097/ALN.0000000000000508 · DOI
  43. 10.3389/fneur.2017.00307 · DOI
  44. 10.1080/00031305.2018.1537889 · DOI
  45. 10.1097/j.pain.0000000000001834 · DOI
  46. 10.1001/jamainternmed.2018.4222 · DOI
  47. 10.1097/jcp.0b013e3180333ed5 · DOI
  48. 10.1016/S0304-3959(99)00082-2 · DOI · Paper page
  49. 10.1016/S0304-3959(98)00064-5 · DOI · Paper page
  50. 10.1371/journal.pbio.1002570 · DOI · Paper page

Cited by

Metadata

Authors
Ferreira, G. E., McLachlan, A. J., Lin, C.-W. C., Zadro, J. R., Abdel-Shaheed, C., O’Keeffe, M., & Maher, C. G.
Venue
BMJ
Publisher
BMJ
Published
2021-01-20
Volume
372
Pages
m4825
ISSN
1756-1833 (ISSN-L)
OpenAlex
W3125643582
Cited by
168
References
20
FWCI
5.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.